SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nutt DJ, King LA, Phillips LD. Drug harms in the UK: A multicriteria decision analysis. Lancet. 2010;376:15581565.
  • 2
    Rehm J, Mathers C, Popova S, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:22232233.
  • 3
    Rehm J, Room R, van den Brink W, et al. Problematic drug use and drug use disorders in EU countries and Norway: An overview of the epidemiology. Eur Neuropsychopharmacol. 2005;15:389397.
  • 4
    Vanyukov MM, Tarter RE, Kirisci L, et al. Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci Biobehav Rev. 2003;27:507515.
  • 5
    Lopez-Quintero C, Cobos JP, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115:120130.
  • 6
    Lynch WJ, Roth ME, Carroll ME. Biological basis of sex differences in drug abuse: Preclinical and clinical studies. Psychopharmacology (Berl). 2002;164:121137.
  • 7
    Grant B, Dawson D, Stinson F, et al. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend. 2004;74:223234.
  • 8
    Stinson F, Grant B, Dawson D, et al. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005;80:105116.
  • 9
    Zilberman M, Tavares H, El-Guebaly N. Gender similarities and differences: The prevalence and course of alcohol- and other substance-related disorders. J Addict Dis. 2003;22:6174.
  • 10
    Lopez-Quintero C, Hasin DS, de Los Cobos JP, et al. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction. 2011;106:657669.
  • 11
    Compton WM III, Cottler LB, Ben Abdallah A, et al. Substance dependence and other psychiatric disorders among drug dependent subjects: Race and gender correlates. Am J Addict. 2000;9:113125.
  • 12
    Wagner FA, Anthony JC. Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug and Alcohol Dependence. 2007;86:191198.
  • 13
    Kloos A, Weller RA, Chan R, et al. Gender differences in adolescent substance abuse. Curr Psychiatry Rep. 2009;11:120126.
  • 14
    Van Etten ML, Anthony JC. Male-female differences in transitions from first drug opportunity to first use: Searching for subgroup variation by age, race, region, and urban status. J Womens Health Gend Based Med. 2001;10:797804.
  • 15
    Grant BF. Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1996;8:195210.
  • 16
    Warner LA, Kessler RC, Hughes M, et al. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:219229.
  • 17
    European Monitoring Centre for Drugs and Drug Addiction. Differences in patterns of drug use between women and men. Luxembourg; 2005.
  • 18
    Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:819.
  • 19
    Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002;26:479488.
  • 20
    Saha TD, Chou SP, Grant BF. Toward an alcohol use disorder continuum using item response theory: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2006;36:931941.
  • 21
    Saha TD, Stinson FS, Grant BF. The role of alcohol consumption in future classifications of alcohol use disorders. Drug Alcohol Depend. 2007;89:8292.
  • 22
    Gelhorn H, Hartman C, Sakai J, et al. Toward DSM-V: An item response theory analysis of the diagnostic process for DSM-IV alcohol abuse and dependence in adolescents. J Am Acad Child Adolesc Psychiatry. 2008;47:13291339.
  • 23
    Hartman CA, Gelhorn H, Crowley TJ, et al. Item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents. J Am Acad Child Adolesc Psychiatry. 2008;47:165173.
  • 24
    Martin CS, Chung T, Langenbucher JW. How should we revise diagnostic criteria for substance use disorders in the DSM-V? J Abnorm Psychol. 2008;117:561575.
  • 25
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
  • 26
    Grant BF, Kaplan K. Source and Accuracy Statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2005.
  • 27
    Huang B, Grant BF, Dawson DA, et al. Race-ethnicity and the prevalence and co-occurrence of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, alcohol and drug use disorders and Axis I and II disorders: United States, 2001 to 2002. Compr Psychiatry. 2006;47:252257.
  • 28
    Grant B, Dawson D, Stinson F, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): Reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71:716.
  • 29
    Compton W, Grant B, Colliver J, et al. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291:21142121.
  • 30
    Grant BF, Dawson DA, Hasin DS. The Alcohol Use Disorder and Associated Disabilites Schedule—DSM-IV Version. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2001.
  • 31
    Cottler LB, Grant BF, Blaine J, et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47:195205.
  • 32
    Hasin D, Carpenter KM, McCloud S, et al. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): Reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44:133141.
  • 33
    Pull CB, Saunders JB, Mavreas V, et al. Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: Results of a cross-national study. Drug Alcohol Depend. 1997;47:207216.
  • 34
    Chatterji S, Saunders JB, Vrasti R, et al. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule—Alcohol/Drug-Revised (AUDADIS-ADR): An international comparison. Drug Alcohol Depend. 1997;47:171185.
  • 35
    Vrasti R, Grant BF, Chatterji S, et al. Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities: Interview Schedule—Alcohol/Drug-Revised. Eur Addict Res. 1998;4:144149.
  • 36
    Grant B, Stinson F, Dawson D, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807816.
  • 37
    Carroll FI, Blough BE, Abraham P, et al. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. J Med Chem. 2009;52:67686781.
  • 38
    Research Triangle Institute. Software for Survey Data Analysis (SUDAAN) version 10.0. Research Triangle Park, NC: Research Triangle Institute; 2008.
  • 39
    Grant BF, Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: Results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1998;10:255264.
  • 40
    Grucza RA, Abbacchi AM, Przybeck TR, et al. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction. 2007;102:623629.
  • 41
    Huang B, Dawson DA, Stinson FS, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67:10621073.
  • 42
    Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006;83:S4S7.
  • 43
    Cotto JH, Davis E, Dowling GJ, et al. Gender effects on drug use, abuse, and dependence: A special analysis of results from the National Survey on Drug Use and Health. Gend Med. 2010;7:402413.
  • 44
    Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004;39:123.
  • 45
    Mumenthaler MS, Taylor JL, O'Hara R, et al. Gender differences in moderate drinking effects. Alcohol Res Health. 1999;23:5564.
  • 46
    Mathew RJ, Wilson WH, Davis R. Postural syncope after marijuana: A transcranial Doppler study of the hemodynamics. Pharmacol Biochem Behav. 2003;75:309318.
  • 47
    Le Strat Y, Ramoz N, Horwood J, et al. First positive reactions to cannabis constitute a priority risk factor for cannabis dependence. Addiction. 2009;104:17101717.
  • 48
    Warner LA, White HR, Johnson V. Alcohol initiation experiences and family history of alcoholism as predictors of problem-drinking trajectories. J Stud Alcohol Drugs. 2007;68:5665.
  • 49
    Reed BG, Mowbray CT. Mental illness and substance abuse: Implications for women's health and health care access. J Am Med Womens Assoc. 1999;54:7178.
  • 50
    Huselid RF, Cooper ML. Gender roles as mediators of sex differences in adolescent alcohol use and abuse. J Health Soc Behav. 1992;33:348362.
  • 51
    Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatric Clin North America. 1999;22:241252.
  • 52
    Greenfield SF, Back SE, Lawson K, et al. Substance abuse in women. Psychiatric Clin North America. 2010;33:339355.
  • 53
    Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: A systematic review. Addiction. 2006;101:181191.
  • 54
    Stein MD, Herman DS, Anderson BJ. A motivational intervention trial to reduce cocaine use. J Subst Abuse Treat. 2009;36:118125.
  • 55
    Degenhardt L, Chiu WT, Sampson N, et al. Epidemiological patterns of extra-medical drug use in the United States: Evidence from the National Comorbidity Survey Replication, 2001–2003. Drug Alcohol Depend. 2007;90:210223.
  • 56
    Bondy SJ, Victor JC, Diemert LM. Origin and use of the 100 cigarette criterion in tobacco surveys. Tob Control. 2009;18:317323.
  • 57
    NIDA. National Household Survey of Drug Abuse 2000–2001. 2000–2001; http://www.drugabusestatistics.samhsa.gov/nhsda/2k1nhsda/vol3/Sect2v1_PDF_W_30-34.pdf. Accessed October 22, 2010.
  • 58
    Grant B, Harford T, Muthén B, et al. DSM-IV alcohol dependence and abuse: Further evidence of validity in the general population. Drug Alcohol Depend. 2007;86:154166.
  • 59
    Ustun B, Compton W, Mager D, et al. WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: Overview of methods and results. Drug Alcohol Depend. 1997;47:161169.